India IVF’s Dr. Richika Sahay & Dr. Somendra Shukla. Image: India IVF

India IVF, a tech-enabled fertility provider, has secured $1.25 million in pre-Series A funding from Tomorrow Capital. This marks the company’s first external investment since its founding in 2014 by Dr. Richika Sahay and Dr. Somendra Shukla, following a decade of profitable operations across five North Indian centers.

The investment aims to support India IVF’s expansion across North India, addressing critical gaps in fertility care access. The company has established what it describes as India’s first tech-enabled fertility platform, offering comprehensive fertility care through advanced technology and expert support.

“India IVF has shown remarkable growth and a deep understanding of the unique fertility challenges faced by many Indian couples. With a tech-enabled, patient-focused approach, they deliver high-quality personalized care, addressing the often-emotional & stigma attached journey of the fertility treatment,” said Rahul Saha, Senior Principal at Tomorrow Capital. “Tomorrow Capital backs ventures that drive meaningful impact, and with India IVF, we’re proud to enable access to essential fertility care across underserved regions in India. We believe their innovative approach will set new standards in India’s fertility sector, and we are excited to support their mission to make fertility care more accessible across the country.”

The investment comes at a crucial time for India’s IVF market, which is projected to grow. This growth is driven by rising infertility rates, increased IVF adoption, and regulatory advancements such as the ART Act, which is establishing higher standards for clinic infrastructure.

“This partnership will empower us to expand our network and bring advanced fertility solutions to more communities. We look forward to making a positive impact on more families and growing India IVF into a trusted national brand,” said Dr. Somendra Shukla, Co-Founder and CEO of India IVF.

Dr. Richika Sahay, Co-Founder and Medical Director, highlighted the scale of India’s fertility challenges: “Approximately 30 million couples in India suffer from infertility, yet only 10% receive proper treatment due to limited access to fertility care. Our mission is to leverage technology and innovation to deliver quality, affordable, and empathetic fertility care to everyone. With Tomorrow Capital’s support, we are well-positioned to expand access to fertility care across North India.”

The company has evolved from a single-room clinic in Gurgaon to establish presence across Noida, Ghaziabad, Delhi, Gurgaon, and Srinagar. India IVF’s comprehensive approach extends beyond clinical care to include emotional, social, financial, and psychological support through a team of psychologists, counselors, dietitians, and yoga and meditation trainers. The company maintains accreditations from the Department of Health, Government of India, PCPNDT, ICMR, and NABH.

Show CommentsClose Comments

Leave a comment